Quest Diagnostics (DGX)
(Delayed Data from NYSE)
$134.26 USD
-1.16 (-0.86%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $134.26 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Industry / Sector Report
Industry : Medical - Outpatient and Home Healthcare
Zacks Industry Rank
Bottom 40% (151 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.47 | 1.68 | 9.99 |
Current Quarter Estimate | 2.32 | 0.69 | 60.00 |
Year Ago Quarter Estimate | 2.30 | 1.31 | 52.54 |
Next Quarter Estimate | 2.30 | 0.72 | 61.00 |
Next Year Estimate | 9.43 | 5.93 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 0.80 | 12.00 | 17.08 |
Next Year | 7.40 | 17.20 | 8.00 |
Last 5 Years | 7.40 | 6.50 | 8.10 |
Next 5 Years | 5.20 | 11.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 15.41 | 13.83 |
Price/Book (MRQ) | 2.31 | 2.28 |
Price/Cash Flow (MRFY) | 10.53 | 12.17 |
Dividend Yield | 2.12% | 0.00% |
Net Profit Margin (TTM) | 9.11% | -88.48% |
Return on Equity (TTM) | 15.52% | -50.54% |
Debt to Equity (MRQ) | 0.59 | 0.29 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.